Related Experiment Video

Updated: Jul 15, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

IGFBP-3 regulates esophageal tumor growth through IGF-dependent and independent mechanisms

Munenori Takaoka1, Seok-Hyun Kim, Takaomi Okawa

  • 1Gastroengerology Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Cancer Biology & Therapy
|April 26, 2007
PubMed

Insights

Insulin-like growth factor binding protein-3 (IGFBP-3) plays a dual role in esophageal cancer. It can inhibit tumor growth via IGF-dependent pathways or promote it through IGF-independent mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Insulin-like growth factor binding protein-3 (IGFBP-3) has context-dependent effects, acting as a proapoptotic or growth-stimulatory factor.
  • IGFBP-3 is frequently overexpressed in esophageal cancer, but its precise role in tumor biology is not fully understood.

Purpose of the Study:

  • To investigate the functional consequences of IGFBP-3 overexpression in human esophageal cells.
  • To elucidate the mechanisms by which IGFBP-3 influences esophageal tumor development and progression.

Main Methods:

  • Stable transduction of Ha-Ras(V12)-transformed human esophageal cells with wild-type or mutant IGFBP-3 (IGF-binding deficient).
  • Assessment of IGF-1 receptor and AKT activation, anchorage-independent cell growth, and tumor formation in xenograft models using in vivo bioluminescence imaging.
  • Analysis of apoptosis induction and caspase-3 cleavage in tumor tissues.

Main Results:

  • Wild-type IGFBP-3 inhibited IGF-1 signaling, suppressed anchorage-independent growth, and abrogated tumor formation in vivo with concurrent apoptosis induction.
  • Mutant IGFBP-3, incapable of binding IGFs, did not inhibit IGF-1 signaling but promoted aggressive tumor growth independently of IGFs and without significant apoptosis.

Conclusions:

  • IGFBP-3 contributes to esophageal tumor development and progression through both IGF-dependent and IGF-independent mechanisms.
  • The dual role of IGFBP-3 highlights its complex involvement in cancer, suggesting potential therapeutic targeting strategies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...